R&D, analytical work, pilot support, QC and GMP operations for selected non-sterile liquid and semisolid products. Site allocation follows the approved scope and the project’s technical requirements.
Sikalias building · 7 Kyklaminon, Peristeri
SITE 1
Industrial scale & broader dosage forms
3–5 Stilianou Gonata str., Peristeri Industrial Park, 12133, Greece
Site 1 now also has GMP certification. QA provides the current certificate, manufacturing authorisations and exact scope for each proposed dosage form and project. Site allocation and any backup production depend on the applicable scope, technology transfer, validation and available capacity.
Supply continuity starts with planning
Two complementary sites broaden scheduling and development options. Alternate-site manufacturing requires the appropriate technical transfer, qualification, capacity and regulatory approvals; it is established within the supply agreement.
Nearshoring for complex molecules and biotechnology startups: from formulation and technology-transfer assessment to an agreed non-sterile manufacturing programme in Athens.